Farmacognosia, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Instituto Multidisciplinario de Biología Vegetal-IMBIV-CONICET, Córdoba, Argentina.
Planta Med. 2012 Jun;78(10):981-7. doi: 10.1055/s-0031-1298627. Epub 2012 Jun 6.
In previous studies, 2',4'-dihydroxy-5'-(1''',1'''-dimethylallyl)-6-prenylpinocembrin, a prenylated flavonoid isolated from Dalea elegans roots, showed activity against multiresistant Staphylococcus aureus and Candida albicans, as well as an uncoupling effect on mitochondria and antioxidant activity. The aim of this study was to evaluate the inhibitory effects of 2',4'-dihydroxy-5'-(1''',1'''-dimethylallyl)-6-prenylpinocembrin and fluconazole on the efflux of rhodamine 6 G in azole-resistant C. albicans 12-99 that expresses multidrug transporters Cdr1p, Cdr2p, and Mdr1p. The effect of fluconazole and 2',4'-dihydroxy-5'-(1''',1'''-dimethylallyl)-6-prenylpinocembrin on rhodamine 6 G efflux was assessed in both azole-sensitive and azole-resistant C. albicans. Between 1 and 1000 µM, 2',4'-dihydroxy-5'-(1''',1'''-dimethylallyl)-6-prenylpinocembrin inhibited rhodamine 6 G efflux only in azole-resistant C. albicans 12-99 in a concentration-dependent manner (IC50 = 119 µM); a competitive effect was observed. It also showed selectivity of action in comparison with other flavanones (6-prenylpinocembrin, isolated from aerial parts of D. elegans, pinocembrin, naringenin, and hesperetin, all at 250 µM). To check the possible implications of the inhibition of azole efflux on cell growth, antifungal assays were conducted. Minimal inhibitory concentration values were 150 µM for 2',4'-dihydroxy-5'-(1''',1'''-dimethylallyl)-6-prenylpinocembrin and higher than 400 µM for fluconazole. The combination of both compounds at either inhibitory or subinhibitory concentrations was significantly more effective than each compound separately. Minimal inhibitory concentration for fluconazole decreased by more than 400 times in the presence of 100 µM 2',4'-dihydroxy-5'-(1''',1'''-dimethylallyl)-6-prenylpinocembrin, reversing azole resistance and giving values similar to those of azole-sensitive C. albicans. These data are consistent with a dual action of 2',4'-dihydroxy-5'-(1''',1'''-dimethylallyl)-6-prenylpinocembrin: direct antifungal effect on azole-resistant C. albicans 12-99 and inhibition of azole transporters, which results in reversion of fluconazole resistance.
在之前的研究中,从 Dalea elegans 根部分离得到的一种被称为 2',4'-二羟基-5'-(1''',1'''-二甲基烯丙基)-6-异戊烯基 pinocembrin 的被酰化黄酮类化合物,表现出对多药耐药金黄色葡萄球菌和白色念珠菌的活性,以及对线粒体的解偶联作用和抗氧化活性。本研究旨在评估 2',4'-二羟基-5'-(1''',1'''-二甲基烯丙基)-6-异戊烯基 pinocembrin 和氟康唑对表达多药转运蛋白 Cdr1p、Cdr2p 和 Mdr1p 的唑类耐药白色念珠菌 12-99 中罗丹明 6G 外排的抑制作用。在唑类敏感和唑类耐药的白色念珠菌中,评估了氟康唑和 2',4'-二羟基-5'-(1''',1'''-二甲基烯丙基)-6-异戊烯基 pinocembrin 对罗丹明 6G 外排的影响。在 1 至 1000 µM 之间,2',4'-二羟基-5'-(1''',1'''-二甲基烯丙基)-6-异戊烯基 pinocembrin 以浓度依赖性方式仅在唑类耐药的白色念珠菌 12-99 中抑制罗丹明 6G 外排(IC50=119 µM);观察到竞争效应。与其他几种黄烷酮(6-异戊烯基 pinocembrin,从 Dalea elegans 的地上部分分离得到,pinocembrin、柚皮苷和橙皮苷,均在 250 µM 时)相比,它还显示出选择性作用。为了检查唑类药物外排抑制对细胞生长的可能影响,进行了抗真菌测定。对于 2',4'-二羟基-5'-(1''',1'''-二甲基烯丙基)-6-异戊烯基 pinocembrin,最小抑菌浓度值为 150 µM,而对于氟康唑则高于 400 µM。在抑制或亚抑制浓度下组合使用这两种化合物比单独使用每种化合物更有效。在存在 100 µM 2',4'-二羟基-5'-(1''',1'''-二甲基烯丙基)-6-异戊烯基 pinocembrin 的情况下,氟康唑的最小抑菌浓度降低了 400 多倍,逆转了唑类耐药性,使其数值与唑类敏感的白色念珠菌相似。这些数据与 2',4'-二羟基-5'-(1''',1'''-二甲基烯丙基)-6-异戊烯基 pinocembrin 的双重作用一致:直接抗真菌作用于唑类耐药的白色念珠菌 12-99 和抑制唑类转运蛋白,从而导致氟康唑耐药性的逆转。